CME 10-K Analysis: Record Volumes Mask a Rate-Dependent Profit Engine

CME Group, the world's largest derivatives exchange, posted record revenue of $6.5 billion and record average daily volume of 28.1 million contracts in FY2025. But the most important number in the 10-K isn't on the income statement — it's buried in the balance sheet: $164.1 billion in customer performance bond cash, up 61% from the prior year, generating $5.25 billion in gross investment income.

That single line item contributed more to pretax income growth than the entire exchange fee business. Headline net income grew 15.5% to $4.02 billion, and Wall Street celebrated a fourth consecutive year of records. What the earnings coverage missed: 62% of that pretax income growth came from non-operating sources — collateral investment income and a one-time $306 million gain from selling its stake in OSTTRA. Operating income from the core exchange business grew only 7.6%.

CME isn't just the world's largest derivatives exchange. It's a $164 billion money market fund with a clearinghouse attached. And at 24.4x trailing earnings with a 97.8% dividend payout ratio, investors need to ask: are they paying for a dominant exchange franchise, or for a rate bet they didn't sign up for?

The $164 Billion Hidden Engine

CME Group operates the world's largest financial derivatives exchange across six asset classes: interest rates, equity indices, energy, agriculture, metals, and foreign exchange. Revenue comes three ways: clearing and transaction fees per contract (~80% of revenue), market data subscriptions ($803 million, +13% YoY), and cash markets fees through BrokerTec and EBS ($283.7 million). The vertically integrated clearinghouse creates a liquidity flywheel — traders concentrate at CME because volume begets tighter spreads, which attracts more volume, which deepens the margin-offset pool.

But there's a fourth revenue stream that most exchange analysis ignores: CME earns investment income by reinvesting the $164.1 billion in customer performance bond collateral that its clearinghouse holds. The 10-K's accounting policies spell out the mechanism.

"Performance bonds and guaranty fund contributions received in the form of cash held by CME may be invested in U.S. government securities, U.S. government agency securities and certain foreign government securities acquired through and held by a bank or broker-dealer subsidiary of a bank, a cash account at the Federal Reserve Bank of Chicago, investments in highly rated government securities, money market funds or through CME's Interest Earning Facility (IEF) program. Any interest earned on these investments accrues to CME."

That last sentence is the critical detail: "Any interest earned on these investments accrues to CME." In FY2025, this collateral pool generated $5.25 billion in gross investment income at an implied yield of approximately 3.95% . CME retains roughly 20% after distributing returns to clearing members, contributing approximately $1.1 billion in net non-operating income (excluding the OSTTRA gain).

The carry trade asymmetry makes this even more compelling. CME holds $3.45 billion in fixed-rate debt at a 4.07% weighted average coupon across five tranches — while earning on a collateral pool 47 times larger that reprices at short-term rates. A 100 basis point shift in rates affects the $164 billion pool by roughly $1.3 billion in gross income but only moves debt costs by $34.5 million. CME has built a structural one-way bet on interest rates.

This three-engine decomposition reframes CME's investment case. Engine 1 — the core exchange business — is management-controlled and grew a respectable 7.6%. But Engine 2 — the collateral investment machine — drove the majority of non-operating income growth (+80.5% YoY) and is entirely outside management's control. And unlike a bank that can absorb rate headwinds by reducing buybacks or building reserves, CME's 97.8% payout ratio means any Engine 2 contraction flows directly to the variable dividend. CME Group earns $5.25 billion in gross investment income by reinvesting $164 billion in customer collateral, making its earnings more sensitive to Federal Reserve rate decisions than to trading volume growth.

The Earnings Illusion

CME reported a headline 15.5% increase in net income, reaching $4.02 billion and diluted EPS of $11.16. At 24.4x trailing earnings, that growth rate appears to justify the premium multiple. But decomposing the sources of that growth reveals a more complicated picture.

The OSTTRA gain created a Q4 optical illusion. CME sold its 50% stake in the post-trade solutions joint venture to KKR for approximately $1.55 billion, generating a $306.1 million pretax gain concentrated entirely in Q4. The result: Q4 GAAP EPS of $3.24 versus adjusted EPS of $2.77 — a $0.47 gap from one transaction. But zoom out to the full year and something counterintuitive emerges: adjusted EPS of $11.20 actually exceeds GAAP EPS of $11.16 by $0.04. The intangible amortization add-back (~$224 million annually) and other excluded items more than offset the OSTTRA removal on a full-year basis. This is not a company inflating results through non-GAAP adjustments — it's a rare case of management's adjusted metric being essentially equivalent to GAAP, signaling conservative accounting.

The more important finding is the 62% figure. Pretax income grew $789 million year-over-year ($4,541 million to $5,331 million). Of that, $491 million came from non-operating income — the collateral investment machine plus the OSTTRA gain. Operating income contributed $298 million. In other words, for every dollar of pretax income growth, 62 cents came from sources outside the exchange business.

"The overall effective tax rate increased in 2025 when compared with the same period in 2024. The increase is largely due to changes in our state and local apportionment factors including remeasurement of our deferred taxes during the year."

On top of the earnings quality question, a 120 basis point increase in the effective tax rate (22.4% to 23.6%) created an approximately $64 million drag on net income . The tax headwind was driven by state apportionment changes, not federal policy — meaning it's structural rather than one-time. CME Group's non-operating income contributed 62% of FY2025 pretax income growth, while operating income from the core exchange business grew only 7.6% year-over-year.

The Unbreakable Machine

If CME's Engine 2 is the rate-dependent variable, Engine 1 — the core exchange franchise — is the floor. And that floor is reinforced by arguably the most durable competitive moat in financial infrastructure.

The 10-K quantifies this moat with a number that appears nowhere in sell-side research.

"In 2025, the average daily margin saving was approximately $72 billion."

That $72 billion per day represents the capital that clearing members would need to post separately at competing venues if they migrated away from CME's portfolio margining system. Across six asset classes, CME's clearinghouse offsets correlated positions — a long Treasury future against a short eurodollar contract, for example — reducing the aggregate margin required. No competitor can replicate this efficiency without matching CME's product breadth and the associated liquidity pools across interest rates, equity indices, energy, agriculture, metals, and foreign exchange simultaneously.

The operating economics reflect this dominance. Revenue grew 6.4% to $6,520.6 million while operating expenses increased only 4.2% to $2,291.1 million, producing a 76.3% incremental operating margin . Every incremental dollar of revenue generates 76 cents of operating profit — the economic signature of a platform with near-zero marginal cost.

Record average daily volume of 28.1 million contracts was driven by broad-based demand. The CEO cited a "risk-always-on environment" with commodities trading up 12% and financials up 5%. Counter to consensus, the fastest-growing product through the nine months ended September 2025 was agricultural commodities — clearing fees of $495.0 million versus $432.5 million a year earlier, a 14.4% increase driven by tariff uncertainty, grain supply disruptions, and weather volatility. This compares to interest rates (+5.3%), equity indices (+4.8%), energy (+1.8%), and foreign exchange (+0.3%) over the same period. Note: full-year agricultural figures are not separately disclosed in the 10-K.

International growth added further momentum. Non-U.S. Q4 ADV reached 8.3 million contracts, up 9% year-over-year, with Asia surging 18%. The capex required to support all of this: just $83.5 million — 1.3% of revenue — reflecting the asset-light nature of an electronic exchange. CME Group's clearinghouse saves customers approximately $72 billion per day in margin requirements, creating a switching cost that no competitor can replicate without matching its liquidity across six asset classes.

The Dividend Tightrope

CME's only near-term growth initiative that could offset rate-cycle risk is a product with zero current revenue and explicit regulatory uncertainty. FanDuel Predicts, a joint venture launched December 22, 2025, gives CME a 50% revenue share on retail event contracts covering S&P 500 outcomes, oil, gold, crypto, GDP, CPI, and sports — available for as little as $1 in five states with planned national expansion in 2026. It represents CME's first direct-to-retail product and a potentially transformative TAM expansion. But the 10-K explicitly flags "litigation and regulatory consideration of issues relating to prediction markets" as a risk factor. The initiative is binary: either regulation permits national expansion and CME captures a new retail audience, or litigation shuts it down before it generates material revenue.

Meanwhile, the Google Cloud Universal Ledger initiative — a partnership exploring asset tokenization, 24/7 trading, and real-time settlement — has a concrete near-term milestone. CME expects to complete the migration of clearing applications to Google Cloud by end of Q1 2026, with legacy on-premises systems decommissioned afterward. Google is building a new private cloud region in Aurora, Illinois for ultra-low-latency trading. But like FanDuel Predicts, GCUL generates zero revenue today.

Neither initiative changes the near-term math on CME's capital return model. The dividend payout ratio improved from 102.9% in FY2024 — when dividends exceeded net income — to 97.8% in FY2025. That improvement is real but still leaves virtually no retained earnings buffer.

"We intend to continue to pay a regular quarterly dividend to our shareholders, with a target of between 50% to 60% of the prior year's cash earnings."

CME's variable dividend structure works like this: a regular quarterly dividend of $1.30 per share ($5.20 annually) plus an annual variable dividend ($6.15 in FY2025), with the variable component targeting 50-60% of prior-year cash earnings. The variable dividend is backward-looking by design — it distributes what was earned last year, not what is expected next year. This creates procyclicality: if Engine 2 contracts in FY2026 due to rate cuts, the variable dividend won't adjust until FY2027, potentially pushing the payout ratio above 100% again.

The contrast with bank peers is stark. Morgan Stanley, Wells Fargo, and Citigroup retain 59-73% of earnings, giving them substantial capital flexibility to absorb rate headwinds through reserve building, buyback reduction, or balance sheet optimization. CME retains 2.2%. The exchange's asset-light model means it doesn't need retained earnings for regulatory capital — but it also means there's no buffer between the income statement and the dividend check. CME Group's 97.8% dividend payout ratio leaves virtually no retained earnings buffer, meaning any decline in its rate-dependent collateral income would force a visible cut to the variable dividend.

What to Watch

The Three-Engine Decomposition frames what matters going forward. Engine 1 — the core exchange business — provides a durable floor with 76.3% incremental margins and a $72 billion-per-day moat. Engine 2 — the collateral investment machine — is the swing factor that drives earnings momentum when rates are high and compresses margins when rates fall. Engine 3 — the OSTTRA gain — is gone and won't recur.

At $273 and 24.4x trailing earnings, CME's valuation implies continued contribution from all three engines. The 5-year FCF per share CAGR of 10.6% projects to approximately $19.30 by FY2030. At a terminal 22x P/FCF — anchored to exchange peer comps where ICE trades at approximately 21-23x and CBOE at approximately 22x — that implies a price near $425 and an annualized return of roughly 9% plus the approximately 4% dividend yield. This looks reasonable if the rate environment holds. If it doesn't, the math changes quickly.

Five metrics to track:

1. Fed funds rate trajectory: A 100bps cut reduces gross investment income by an estimated $1.3 billion annually (approximately -$0.85 to -$1.40 in EPS). Monitor the collateral pool yield versus the prior quarter — this is the earliest signal of Engine 2 contraction.

2. Variable dividend declaration (February 2027): The FY2026 variable dividend will be the first test of whether earnings power held through 2026. If it falls below $6.00 per share (versus $6.15 in FY2025), Engine 2 has started contracting.

3. ADV momentum above 28M: Record FY2025 ADV of 28.1 million contracts sets a high bar. If ADV falls below 26 million for any quarter, Engine 1's 7-8% organic growth assumption is at risk.

4. FanDuel Predicts regulatory rulings: Any adverse court decision or CFTC action on event contracts could eliminate CME's only new retail TAM. Conversely, national expansion authorization in additional states would be a positive catalyst.

5. Q1 2026 Google Cloud migration completion: Management committed to completing clearing application migration by end of Q1 2026. Execution on this timeline validates GCUL optionality; delays raise questions about the tokenization roadmap.

At $273 per share, the market implies that CME's Engine 2 will sustain current contribution levels. The filing supports Engine 1's structural dominance — 76.3% incremental margins and $72 billion in daily margin savings are unassailable — but complicates the bull case by revealing that 62% of the earnings growth investors are paying 24x for is rate-dependent, non-recurring, or both.

Frequently Asked Questions

What is CME Group's performance bond collateral pool and why does it matter?

CME Group's clearinghouse holds $164.1 billion in customer performance bond deposits as of December 31, 2025, up 61% from $101.8 billion at year-end 2024. These margin deposits guarantee futures and options positions. CME reinvests this cash in U.S. government securities, agency bonds, and money market funds, retaining the interest earned. In FY2025, this pool generated $5.25 billion in gross investment income. This matters because it makes CME structurally rate-sensitive — the company earns more when short-term interest rates are high, and this income stream dwarfs annual revenue growth from core exchange fees.

How much of CME's FY2025 earnings growth was organic?

Headline net income grew 15.5% ($3,482M to $4,021M), but this includes a $306.1 million pretax gain from selling OSTTRA to KKR. Stripping this gain, organic NI growth was approximately 10.7%. Furthermore, non-operating income contributed 62% of pretax income growth, while operating income from the core exchange business grew only 7.6%. The three-engine decomposition reveals that CME's earnings growth is primarily driven by factors outside its core fee-based exchange business.

Is CME's dividend sustainable at 97.8% payout?

CME's FY2025 dividend payout ratio was 97.8% of net income, improved from 102.9% in FY2024 when dividends exceeded earnings. CME uses a unique variable dividend structure: a regular quarterly dividend ($1.30/quarter = $5.20/year) targeting 50-60% of prior-year cash earnings, plus an annual variable dividend ($6.15 in FY2025). The variable component provides a built-in buffer — it automatically adjusts downward when earnings decline. However, any visible cut to the variable dividend would likely be a negative market signal.

How does CME's clearing moat compare to competitors?

CME's 10-K discloses that its clearing and portfolio margining saved customers approximately $72 billion per day in margin requirements in 2025. No competitor — including FMX, ICE, or LCH — can replicate this margin efficiency without matching CME's product breadth across six asset classes and the associated liquidity pools. The clearinghouse serves as counterparty to every trade, eliminating bilateral credit risk, creating near-unbreakable customer stickiness.

What is the OSTTRA gain and how should investors treat it?

CME sold its 50% interest in OSTTRA to KKR for approximately $1.55 billion, closing October 2025. The transaction generated a $306.1 million pretax gain concentrated in Q4. Full-year adjusted EPS ($11.20) actually exceeds GAAP EPS ($11.16) because intangible amortization add-backs more than offset the OSTTRA removal. Investors should treat Q4 cautiously (GAAP inflated by $0.47/share) but recognize that on a full-year basis, GAAP and adjusted are essentially equivalent — indicating conservative reporting.

How rate-sensitive is CME's business?

CME's rate sensitivity operates through two channels: (1) the $164.1 billion collateral pool earns approximately 3.95% implied yield, repricing at short-term rates; and (2) $3.45 billion in fixed-rate debt at 4.07% weighted average coupon. A 100bps decline in Fed funds could reduce gross investment income by approximately $1.3 billion annually. The net EPS impact: approximately -$0.85 to -$1.40/share , material against consensus FY2026 EPS of $11.73.

What is FanDuel Predicts and how significant is it for CME?

FanDuel Predicts is a joint venture launched December 22, 2025 where CME earns 50% of gross revenue from retail event contracts on S&P 500, oil, gold, crypto, GDP, CPI, and sports outcomes. It launched in 5 states with planned national expansion in 2026. FY2025 revenue was zero. The 10-K explicitly flags "litigation and regulatory consideration of issues relating to prediction markets" as a risk factor. The significance is strategic — a new direct-to-retail TAM — but comes with binary regulatory risk.

Why does CME trade at a premium to bank stocks?

CME trades at 24.4x trailing earnings vs. 10-17x for bank peers (MS, WFC, C, RY). The premium reflects 61.7% net margins (vs 15-31% for banks), 27.9% ROTCE (vs 8-19%), a clearing monopoly with $72B daily margin savings, and asset-light economics requiring just $83.5M capex on $6.5B revenue. The discount: at 98% payout, CME retains almost nothing for growth, and its collateral income reprices immediately with short-term rates — more directly rate-sensitive than bank NII.

What was CME's fastest-growing product line in FY2025?

Agricultural commodities, with 9-month 2025 clearing fees of $495.0 million vs. $432.5 million year-ago — a 14.4% increase. This compares to interest rates +5.3%, equity indices +4.8%, energy +1.8%, and FX +0.3% over the same period. Note: this is 9-month data; full-year figures are not separately disclosed. Growth was driven by tariff uncertainty, grain supply disruptions, and weather volatility.

What is CME's Google Cloud Universal Ledger initiative?

GCUL is a joint initiative with Google Cloud to explore asset tokenization, potentially enabling 24/7 trading, tokenized collateral, and real-time settlement. CME expects to complete clearing application migration to Google Cloud by end of Q1 2026, followed by decommissioning legacy on-premises systems. Google is building a new private cloud region in Aurora, Illinois for ultra-low-latency trading. The initiative generates zero revenue today but represents significant long-term optionality.

Methodology

Data Sources

This analysis draws on three primary sources:

• CME Group FY2025 10-K (filed February 26, 2026): Sections analyzed include risk_factors, mda_results_operations, mda_liquidity, footnote_debt, footnote_segment, footnote_accounting_policies, footnote_revenue, business_description, and mda_critical_accounting.
• CME Group Q4/FY2025 8-K Earnings Release (February 4, 2026): GAAP reconciliation, earnings per share tables, and CEO commentary.
• MetricDuck Metrics Pipeline: Standardized financial metrics extracted from XBRL filings for CME and peer companies (MS, WFC, C, RY). All pipeline-sourced Tier A numbers were verified against filing text.

Peer financial data (Morgan Stanley, Wells Fargo, Citigroup, Royal Bank of Canada) comes from MetricDuck's automated XBRL extraction pipeline. These are CME's clearing members (customers), not exchange competitors — the comparison illuminates CME's role in the financial ecosystem but is not an operational comp. True exchange peers (ICE, CBOE, NDAQ) would provide more meaningful margin and valuation benchmarks.

Limitations

• Net investment income decomposition is approximate. Gross investment income ($5.25B) and total non-operating income ($1.10B) are disclosed, but the exact allocation between collateral returns, equity earnings from unconsolidated subsidiaries, and other items is estimated. The ~20% net retention rate is derived, not disclosed.
• Implied collateral yield uses simple average. The ~3.95% yield is calculated as $5,253.6M divided by the average of beginning ($101.8B) and ending ($164.1B) collateral balances. Because the pool grew 61% during the year, the simple average ($133B) understates the time-weighted average — the actual yield was likely higher than 3.95%. Treat this as a floor estimate.
• Agriculture growth is 9-month data. The 14.4% figure comes from quarterly 10-Q revenue footnotes ($495.0M vs $432.5M), not the annual 10-K. Full-year agricultural clearing fees are not separately disclosed.
• Pipeline debt data gap. The metrics pipeline reports CME total debt as $0, but the filing discloses $3.42B across 5 tranches. All debt-related metrics in this analysis use filing-sourced figures.
• RY dividend data unavailable in USD XBRL. Royal Bank of Canada's payout ratio appears as 0% in pipeline data; RY actually pays approximately C$5.68 per share annually (~3.3% yield). RY is excluded from the dividend comparison table.
• Rate sensitivity estimate is directional. The -$0.85 to -$1.40 EPS impact from a 100bps rate cut depends on collateral pool composition, reinvestment timing, and distribution schedules to clearing members, which are not fully disclosed.

Disclaimer:

This analysis is for informational purposes only and does not constitute investment advice. The author does not hold positions in CME, MS, WFC, C, or RY. Past performance and current metrics do not guarantee future results. All data is derived from public SEC filings and may contain errors or omissions from the automated extraction process.